{"slideshow_credits": null, "snippet": "For desperate patients, the pace of clinical drug trials can be lethally slow. But there is a way for them to beat the clock.", "abstract": "Darshak Sanghavi article describes how patients dying from cancer can obtain experimental drugs through a Food and Drug Administration program called compassionate access, in which pharmaceutical companies are allowed to offer them promising drugs that are still being tested.", "section_name": "Magazine", "print_page": "40", "document_type": "article", "byline": {"person": [{"firstname": "Darshak", "role": "reported", "rank": 1, "organization": ""}], "original": "By DARSHAK M. SANGHAVI, M.D", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/11/03/magazine/how-dying-patients-get-access-to-experimental-drugs.html", "lead_paragraph": "For desperate patients, the pace of clinical drug trials can be lethally slow. But there is a way for them to beat the clock.", "headline": {"seo": "How Dying Patients Get Access to Experimental Drugs", "main": "The Pills of Last Resort", "print_headline": "The Pharmaceutical Hail Mary"}, "_id": "52721c2738f0d869cf22d6d6", "word_count": "2750", "multimedia": [{"height": 126, "url": "images/2013/11/03/magazine/03drugs/03drugs-thumbWide-v2.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/11/03/magazine/03drugs/03drugs-thumbWide-v2.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 494, "url": "images/2013/11/03/magazine/03drugs/03drugs-articleLarge-v3.jpg", "legacy": {"xlarge": "images/2013/11/03/magazine/03drugs/03drugs-articleLarge-v3.jpg", "xlargewidth": "600", "xlargeheight": "494"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/11/03/magazine/03drugs/mag-03Drugs-t_CA0-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/11/03/magazine/03drugs/mag-03Drugs-t_CA0-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-11-03T00:00:00Z", "source": "The New York Times", "news_desk": "Magazine", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Clinical Trials", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Act Up", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Cancer", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}